NCT04688866

Brief Summary

Pregnant women with short cervical length (\<25 mm) in second-trimester ultrasonographic assessment are at high risk for preterm birth, a major cause of perinatal mortality and morbidity worldwide. Some of these short-cervix women proceed to a more advanced stage manifested as a painless prematurely dilated cervix in the second trimester. It is not fully understood why some women have short cervical length or prematurely dilated cervix (cervical insufficiency), although evidence is mounting that there is an association between short cervical length and infection by microorganisms. The investigators hypothesize that the cervical microorganisms in pregnant women with a shortened or dilated cervix are different, compared with those in women with normal cervical length and a closed cervix.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2012

Completed
8.6 years until next milestone

First Submitted

Initial submission to the registry

December 22, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 30, 2020

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

13.6 years

First QC Date

December 22, 2020

Last Update Submit

October 4, 2023

Conditions

Keywords

preterm birthcervical insufficiencycerclagepessary

Outcome Measures

Primary Outcomes (1)

  • Abundances of microorganisms in the cervix

    Abundances of microorganisms including bacteria and fungi in the cervix are measured by normalized sequencing read counts

    1 year

Secondary Outcomes (3)

  • Gestational age at delivery

    1 year

  • Mode of delivery

    1 year

  • Number of participants who received cerclage or ring pessary in the current pregnancy

    1 year

Study Arms (2)

Pregnant women with cervical insufficiency (Cases)

Pregnant women with a shortened (\<25 mm) or dilated cervix in the second trimester (or late first trimester)

Other: Sequencing

Pregnant women without cervical insufficiency (Controls)

Pregnant women with a normal-length (\>= 25 mm) and closed cervix in the second trimester (or late first trimester)

Other: Sequencing

Interventions

This is an observational study, since the assignment of the medical intervention (e.g. cerclage or pessary) is not at the discretion of the investigator. However, cervical samples collected from both groups are subjected to amplicon sequencing for taxonomic classification of microorganisms.

Pregnant women with cervical insufficiency (Cases)Pregnant women without cervical insufficiency (Controls)

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women who attend preterm clinics or receive antenatal care at the participating hospitals.

You may qualify if:

  • Women with or without cervical insufficiency (cervical length \<25 mm or dilated cervix in the second trimester or the late first trimester)

You may not qualify if:

  • multiple pregnancies and pregnancies associated with fetal chromosomal abnormality

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Research Laboratory, Dept of Obstetrics & Gynaecology, The Chinese University of Hong Kong

Hong Kong, 852, Hong Kong

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Cervical swab samples obtained comprise ample amount of DNA for PCR amplification or sequencing.

MeSH Terms

Conditions

Uterine Cervical IncompetencePremature Birth

Interventions

Base Sequence

Condition Hierarchy (Ancestors)

Uterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesAbortion, HabitualAbortion, SpontaneousPregnancy ComplicationsGenital DiseasesObstetric Labor, PrematureObstetric Labor Complications

Intervention Hierarchy (Ancestors)

Molecular StructureBiochemical PhenomenaChemical PhenomenaGenetic StructuresGenetic Phenomena

Study Officials

  • Stephen S Chim, PhD

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Stephen S Chim, PhD

CONTACT

Karen K Wong, MPhil

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 22, 2020

First Posted

December 30, 2020

Study Start

June 5, 2012

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

October 5, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations